The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance
Open accessAbstract
Tumor drug resistance significantly limits the success of chemotherapy in the clinic. Tumor cells utilize multiple mechanisms to prevent the accumulation of anticancer drugs at their intracellular site of action. In this study, we investigated the anticancer efficacy of doxorubicin in combination with photodynamic therapy using methylene blue in a drug-resistant mouse tumor model. Surfactant-polymer hybrid nanoparticles formulated using an anionic surfactant, Aerosol-OT™ (AOT), and a naturally occurring polysaccharide polymer, sodium alginate, were used for synchronized delivery of the two drugs. Balb/c mice bearing syngeneic JC tumors (mammary adenocarcinoma) were used as a drug-resistant tumor model. Nanoparticle-mediated combination therapy significantly inhibited tumor growth and improved animal survival. Nanoparticle-mediated combination treatment resulted in enhanced tumor accumulation of both doxorubicin and methylene blue, significant inhibition of tumor cell proliferation, and increased induction of apoptosis. These data suggest that nanoparticle-mediated combination chemotherapy and photodynamic therapy using doxorubicin and methylene blue has significant therapeutic potential against drug-resistant tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
Photodynamic therapy and anti-tumour immunity
Castano, A. P., Mroz, P., & Hamblin, M. R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1894 · Cited by 2,676
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Casares, N., Pequignot, M. O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050915 · Cited by 1,512
Cell sheet engineering for myocardial tissue reconstruction
Shimizu, T., Yamato, M., Kikuchi, A., & Okano, T. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00110-8 · Cited by 673
Mechanisms and strategies to overcome multiple drug resistance in cancer
Ozben, T. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.020 · Cited by 406
Bioconjugated Nanoparticles for DNA Protection from Cleavage
He, X.-X., Wang, K., Tan, W., Liu, B., Lin, X., He, C., Li, D., Huang, S., & Li, J. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034450d · Cited by 266
Apoptosis and cancer chemotherapy
Makin, G., & Hickman, J. A. (2000) · Cell and Tissue Research · doi:10.1007/s004419900160 · Cited by 226
Photodynamic Therapy Enhancement of Antitumor Immunity Is Regulated by Neutrophils
Kousis, P. C., Henderson, B. W., Maier, P. G., & Gollnick, S. O. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1778 · Cited by 224
Vascular effects of photodynamic therapy.
Krammer, B. E. (2001) · PubMed · Cited by 219
Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD)
Fingar, V. H., Kik, P. K., Haydon, P. S., Cerrito, P. B., Tseng, M., Abang, E., & Wieman, T. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690271 · Cited by 219
Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model
Castano, A. P., Mroz, P., Wu, M. X., & Hamblin, M. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709256105 · Cited by 201
Immune Modulation by Ionizing Radiation and its Implications for Cancer Immunotherapy
Friedman, E. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023394089 · Cited by 201
Doxorubicin-Induced Cardiac Toxicity
Doroshow, J. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241210 · Cited by 198
Mimeault, M., Hauke, R., & Batra, S. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100296 · Cited by 168
Kabingu, E., Vaughan, L. A., Owczarczak, B., Ramsey, K. D., & Gollnick, S. O. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603792 · Cited by 160
Cardiotoxicity of doxorubicin and other anthracycline derivatives
Jain, D. (2000) · Journal of Nuclear Cardiology · doi:10.1067/mnc.2000.103324 · Cited by 149
Tang, W., Xu, H., Park, E. J., Philbert, M. A., & Kopelman, R. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.066 · Cited by 146
Khdair, A., Handa, H., Mao, G., & Panyam, J. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.017 · Cited by 138
Self-citationVesicular Anthracycline Accumulation in Doxorubicin-Selected U-937 Cells: Participation of Lysosomes
Hurwitz, S. J., Terashima, M., Mizunuma, N., & Slapak, C. A. (1997) · Blood · doi:10.1182/blood.v89.10.3745 · Cited by 137
Differential cell death response to photodynamic therapy is dependent on dose and cell type
Wyld, L., Reed, M., & Brown, N. J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1795 · Cited by 137
Methylene blue mediated photodynamic therapy in experimental colorectal tumors in mice
Orth, K., Beck, G. C., Genze, F., & Rück, A. (2000) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/s1011-1344(00)00105-6 · Cited by 125
Polymer‐surfactant nanoparticles for sustained release of water‐soluble drugs
Chavanpatil, M. D., Khdair, A., Patil, Y. B., Handa, H., Mao, G., & Panyam, J. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20961 · Cited by 124
Self-citationDenoyelle, C., Albanese, P., Uzan, G., Li, H., Vannier, J., Soria, J., & Soria, C. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00124-9 · Cited by 120
Rumjanek, V. M., Trindade, G. S., Wagner-Souza, K., MELETTI-DE-OLIVEIRA, M. C., Marques‐Santos, L. F., Maia, R. C., & Capella, M. A. M. (2001) · Anais da Academia Brasileira de Ciências · doi:10.1590/s0001-37652001000100007 · Cited by 115
Surfactant−Polymer Nanoparticles Enhance the Effectiveness of Anticancer Photodynamic Therapy
Khdair, A., Gérard, B., Handa, H., Mao, G., Shekhar, M. P. V., & Panyam, J. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800026t · Cited by 114
Self-citationChavanpatil, M. D., Khdair, A., & Panyam, J. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9203-2 · Cited by 98
Self-citationRahko, E. K., Blanco, G. A. C., Soini, Y., Bloigu, R., & Jukkola, A. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00499-9 · Cited by 86
Rashmi, R., Kumar, S., & Karunagaran, D. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh001 · Cited by 80
Weinberg, B. D., Ai, H., Blanco, E., Anderson, J. M., & Gao, J. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30914 · Cited by 78
Reduction of thiazine dyes by bovine pulmonary arterial endothelial cells in culture
Bongard, R. D., Merker, M. P., Shundo, R., Okamoto, Y., Roerig, D. L., Linehan, J. H., & DAWSON, C. A. (1995) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1995.269.1.l78 · Cited by 42
Influence of microenvironmental pH on adriamycin resistance.
Alabaster, O., Woods, T., Ortiz-Sanchez, V., & Jahangeer, S. M. (1989) · PubMed · Cited by 35
Cited by
Combination therapy in combating cancer
Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543
Functional Nanomaterials for Phototherapies of Cancer
Cheng, L., Wang, C., Feng, L., Yang, K., & Liu, Z. (2014) · Chemical Reviews · doi:10.1021/cr400532z · Cited by 2,425
Nanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B., Huang, P., & Chen, X. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,791
Sapsford, K. E., Algar, W. R., Berti, L., Gemmill, K. B., Casey, B. J., Oh, E., Stewart, M. H., & Medintz, I. L. (2013) · Chemical Reviews · doi:10.1021/cr300143v · Cited by 1,423
Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 1)
Honary, S., & Zahir, F. (2013) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v12i2.19 · Cited by 1,138
Metadata
- Authors
- Khdair, A., Chen, D., Patil, Y., Ma, L., Dou, Q. P., Shekhar, M. P. V., & Panyam, J.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 141
- Issue
- 2
- Pages
- 137-144
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2155248907
- Cited by
- 275
- References
- 32
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.